drugset / Trial / NCT00261248
Vaccine for Recurrent Urinary Tract Infections in Women
Phase 2
Completed
75 enrolled
University of Wisconsin, Madison
National Institutes of Health (NIH) · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is determine whether a vaginal mucosal vaccine given to women with a history of recurrent urinary tract infections can reduce the number of infections occurring in a six-month study period, as compared to placebo treatment.
Timeline
- Start
- 1996-11
- Primary completion
- —
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | inactivated bacteria | Vaccine | — | Other |